101/12/22

Tw-DRGs

()

()

(Pay for Performance)

(Bundling Payment)

()

(System Integration)
4


1995 FFS+Case
payment
+

1998-2002
Global
Budget

2004 RBRVS

2010 TwDRGs
164

2011
Capitation
Plan

()
(2001)
(2006)
BC
(2010)
(CKD) (2011)
(2012)

(1998.7)
(1999.7)

(2002.7)
(2001.7)

(2003)

(2003.3)
(2009)

(2011)
5

(Bundling
Payment)
84(Fee for service)
(Case Payment)

(per-diem)
87-(Global Budget Payment)
99-

Tw-DRGs
()
100-
6

(Pay for Performance)

90-95

97
91.81%
95-
99-BC
100-CKD

101-
7

(System Integration)

IDS

Tw-DRGs

Tw-DRGs
()
()

10

DRGs
DRGs-(Diagnosis Related
Groups)

11

DRGs

1029
25MDC+PREMDC

DRG

MDC

DRG1 RW1
DRG2 RW2
DRG3
DRG
DRG4

DRG5

DRGn
Variance

12

(Principal Diagnosis)

13

(Principal procedure)

14

/
/Comorbidity

Ex: Fracture of femur, DM

Complication

Ex:S/P Appendectomy, Wound infection

15

MDC(Major Diagnostic Category)

MDC
PRE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
21
22
23
24
UN

6
11
48
24
4
37
6
1
4
2
12
9

164

13
87
36
52
82
110
109
28
135
41
35
44
29
29
32
19
24
15
20
28
31
12
8
10
1029

16

Tw-DRGs
1540.0()47.01()
DRG16401/16501(/)RW1.5055/1.1378
2402.01()+37.21()DRG124/125(
/) RW1.2724/0.9569

1 preMDC
25 MDCs

CC

ICD-9-CM

ICD-9-CM

Alive
Age

CC
Death

17

Tw-DRGs
-
Tw-DRG

18

Tw-DRGs
MDC1920()

>30

ECMO(39.65)

19

DRG
, 3.21%

, 13.19%

, 2.34%

, 0.03%

, 0.16%
DRG, 60.7%

, 0.26%
>30, 19.47%

, 0.42%

(), 1.20%
=DRG/

20

-
DRG

DRG2MDC14(
)DRG
()
IABP(Intra-aortic balloon pump)

21

Tw-DRGs

DRG
2.5

(DRG91
)

DRG

(RW)(SPR)
(1+CMI
)

DRG
+

*0.8
= DRG

22

Tw-DRGs

B
50

C
91

23

Tw-DRGs(RW)

DRG

Tw-DRGs RW=

97DRGDRG

DRGDRG

102-35,920
24


49

100.01.01164

DRGMDC
1
2
()
3
()
4
()

5
()

98.12.17155DRG
(11MDC)
MDC 58121314
(
)
MDC 2367910
(
)
MDC PRE411172324

PRE MDC)
MDC 11516182122(

1017DRG

100.01.011,029

DRG DRG
%
DRG%

28.60%

28.60%

17.36%

18.00%

46.60%

10.97%

14.30%

60.90%

10.26%

21.40%

82.30%

12.97%

17.70%

100.00%

9.16%

100.00%

60.72%
25

DRG

1.
2.

1.

2.

1.
2.

1.
2.
3.

DRG

26

DRG
%

2009

1~2

DRG

DRG
()
() ()
()
1,353,802
-- 82,381
-- 231,241 17.08%
-- 12,165 14.77% --

2010

1~2

1,387,755

2.51% 82,735

0.43% 223,813 16.13%

-3.21% 12,416 15.01%

2.06%

2011

1~2

1,439,131

3.70% 86,869

5.00% 227,773 15.83%

1.77% 12,449 14.33%

0.27%

2012

1~2

1,445,785

0.46% 87,100

0.27% 240,616 16.64%

5.64% 12,994 14.92%

4.38%

DRG5.64%1.28
1
DRG4.38%
0.27%
27

DRG-

28


/%

2009

1~2

4.42

--

2010

1~2

4.18

2011

1~2

2012

4.51

--

4.40

--

4.30

--

-5.26%

4.23 -6.15%

4.16

-5.42%

4.15

-3.57%

4.18

0.03%

4.22 -0.28%

4.19

0.71%

4.12

-0.80%

1~2

4.14

-1.09%

4.22 -0.02%

4.15

-0.88%

3.99

-3.13%

4.13

-1.06%

4.21 -0.19%

4.15

-0.73%

3.96

-3.04%

4.15

-1.10%

4.22

4.16

-1.01%

4.01

-3.19%

0.13%

DRG20121-24.14
4.426.25%4.18
1.09%
1011-23.13%
0.02%3.99-4.22
29


/%

2009 1~2

45,977

--

56,142

--

42,852

--

35,495

--

2010 1~2

45,609

-0.80%

55,632

-0.91%

42,151

-1.64%

35,620

0.35%

2011 1~2

45,298

-0.68%

55,257

-0.67%

42,356

0.49%

34,840

-2.19%

2012 1~2

45,287

-0.02%

56,080

1.49%

42,198

-0.37%

34,457

-1.10%

44,805

-0.08%

55,603

1.03%

41,838

-0.33%

33,824

-0.39%

45,754

0.06%

56,534

1.94%

42,550

-0.38%

35,070

-1.66%

45,977
20121-245,287690
0.02%
1.10%
0.37%1.49%
30

DRG
/%

2009

1~2

52,608

62,858

49,129

42,664

2010

1~2

55,474

66,276

51,445

45,343

2011

1~2

54,654

65,437

50,938

44,412

2012

1~2

54,002

65,402

50,169

43,677

53,442

64,870

49,721

42,965

54,543

65,908

50,608

44,367

20121-254,002
6521,394
20121-2
2012CMI
31

DRG
/%

2009

1~2

1.1442

1.1196

1.1465

1.2020

2010

1~2

1.2163

1.1913

1.2205

1.2730

2011

1~2

1.2065

1.1842

1.2026

1.2748

2012

1~2

1.1924

1.1662

1.1889

1.2676

1.1928

1.1667

1.1884

1.2702

1.1921

1.1658

1.1894

1.2651

DRG20121-2
1.1924DRG

1.2676
1.18891.1662
32

DRG-

33

1
/%

2009 1~2

684

--

842

--

727

--

333

--

2010 1~2

847

23.79%

1,014

20.44%

881

21.10%

486

46.03%

2011 1~2

695

-17.96%

960

-5.36%

651

-26.16%

346

-28.90%

2012 1~2

610

-12.13%

876

-8.80%

537

-17.40%

339

-2.09%

621

-16.93%

904

-13.67%

542

-22.47%

337

-5.47%

600

-7.03%

848

-3.59%

533

-11.96%

340

1.29%

120121-2610
7412.13%201023.79%
20109
Tw-DRGs

17.40%
34
8.80%2.09%

1
/%

2009 1~2

1,190

--

1,287

--

1,237

--

938

--

2010 1~2

1,208

1.56%

1,307

1.55%

1,240

0.23%

973

3.80%

2011 1~2

1,266

4.75%

1,380

5.65%

1,302

5.05%

1,001

2.84%

2012 1~2

1,196

-5.51%

1,317

-4.58%

1,224

-6.03%

952

-4.92%

1,165

-5.70%

1,304

-0.16%

1,183

-8.60%

915

-8.58%

1,226

-5.24%

1,330

-8.19%

1,264

-3.51%

987

-1.37%

120121-2
1,19665.51%
1

35
6.03%4.92%

DRG
%

2009 1~2

11.27%

--

12.62%

--

12.89%

--

6.37%

--

2010 1~2

15.82%

40.37%

17.79%

40.97%

17.22%

33.59%

10.26%

61.07%

2011 1~2

15.02%

-5.06%

18.41%

3.49%

15.86%

-7.90%

9.18%

-10.53%

2012 1~2

13.88%

-7.59%

17.97%

-2.39%

14.40%

-9.21%

7.92%

-13.73%

13.91%

-7.45%

17.95%

-1.10%

14.61%

-8.34%

7.73%

-18.63%

13.86%

-7.60%

18.00%

-3.59%

14.19%

-10.13%

8.12%

-8.46%

DRG20121-213.88%
7.59%201040.37%
DRG
2011-2012
13.73%
9.21%2.39%
36


-()

37

DRG
%

2009
2010

1~2
1~2

0.35%
0.34%

--2.9%

800
757

2011

1~2

0.28%

-17.6%

639

-15.6%

2012

1~2

0.24%

-14.3%

584

-8.6%

0.24%

-25.0%

288

-17.0%

0.24%

-4.0%

296

1.4%

258
-234
-9.3%

2009
2010

1~2
1~2

0.31%
0.29%

--6.5%

2011

1~2

0.20%

-31.0%

158

2012

1~2

0.17%

-15.0%

0.16%

0.17%

--5.4%

356
-329
-7.6%

183
-194
6.0%

0.36%
0.34%

--5.6%

-32.5%

0.32%

-5.9%

315

-4.3%

0.34%

-19.05%

166

-14.4%

139

-12.0%

0.25%

-21.9%

261

-17.1%

0.35%

2.94%

184

10.8%

-38.5%

67

-33.0%

0.27%

-18.2%

139

-13.1%

0.31%

-16.22%

82

-5.7%

21.4%

72

24.1%

0.23%

-23.3%

122

-21.3%

0.38%

18.75%

102

29.1%

0.38% -0.42%
10.53%

=/DRG

DRG20121-20.24%14.3%
552.94%
38

39

3
%

2009
2010

1~2
1~2

1.57%
1.68%

2011

1~2

2012

-7.01%

3,638
3,768

1.60%

-4.8%

3,643

-3.3%

1~2

1.57%

-1.9%

3,775

3.6%

1.50%

-5.7%

1,774

1.4%

1.64%

2.5%

2,001

5.7%

1.62%
-1,337
1.77%
9.26%
1,413

-3.57%

1.76%
-1,751
1.78%
1.14%
1,735

1.12%
-542
1.33% 18.75%
620

2009
2010

1~2
1~2

2011

1~2

1.64%

-7.3%

1,319

-6.7%

1.69%

-5.1%

1,674

-3.5%

1.34%

0.8%

650

4.8%

2012

1~2

1.71%

4.3%

1,427

8.2%

1.62%

-4.1%

1,691

1.0%

1.24%

-7.5%

657

1.1%

1.65%

6.5%

674

12.7%

1.54%

-11.5%

796

-4.6%

1.16%

-14.7%

304

-4.4%

1.78%

2.9%

753

4.4%

1.70%

3.7%

895

6.5%

1.31%

-0.8%

353

6.3%

-5.68%

--0.91%

-14.39%

320121-21.57%1.9%
3,6433,775132
1374.3%
108
40

14
%

2009
2010
2011
2012

1~2
1~2
1~2
1~2
1
2

2009
2010
2011
2012

1~2
1~2
1~2
1~2
1
2

2.25%
2.59%
2.28%
1.89%
1.86%
1.91%

-15.1%
-12.0%
-17.1%
-19.1%
-15.5%

2.33% -2.66%
14.2%
2.40%
-9.8%
2.09%
-12.9%
2.09%
-15.0%
2.10%
-10.6%

5,399 -5,957
10.3%
5,474
-8.1%
5,042
-7.9%
2,477
-8.2%
2,565
-7.6%

1,854 -2,066 11.4%

1,828 -11.5%
1,570 -14.1%
759 -14.2%
811 -14.0%

2.59%
2.91%
2.76%
2.46%
2.50%
2.42%

-12.4%
-5.2%
-10.9%
-11.7%
-10.4%

2,584 -2,832
9.6%
2,738 -3.3%
2,563 -6.4%
1,290 -4.8%
1,273 -8.0%

1.97% -954 -2.28%

15.7%
1,059
11.0%
1.87%
-18.0%
908
-14.3%
1.71%
-8.6%
909
0.1%
1.63%
-16.8%
428
-6.8%
1.78%
-0.6%
481
7.1%

1420121-22.09%12.9%
5,4745,042432
35717.1%
258
41

CMI
/%

2009

1~2

1.3655

--

1.5788

--

1.2896

--

1.1661

--

2010

1~2

1.3933

2.0%

1.6150

2.3%

1.3112

1.7%

1.1841

1.5%

2011

1~2

1.3850

-0.6%

1.6035

-0.7%

1.3117

0.0%

1.1732

-0.9%

2012

1~2

1.3726

-0.9%

1.5947

-0.5%

1.3005

-0.9%

1.1667

-0.6%

1.3589

-1.1%

1.5816

-1.2%

1.2896

-1.1%

1.1483

0.0%

1.3863

-0.6%

1.6080

0.1%

1.3112

-0.6%

1.1845

-1.0%

CMI20121-21.37260.9%
DRG7.59%

CMI1.59471.30051.1667

42

-1
Tw-DRGs
DRG
1.09%

0.02%
(DRG)

DRG1.1924
20121-2DRG
2009
43

-2
DRG 20121-20.24%
14.3%55
216
3142010

2011-2012

44

TwDRGs

TwDRGs

ICD-10CM/PCS

45

46

46

47

9812
18762

48

48

100

19

71

100

190

(%)

10%

37%

53%

100%

232,596

217,431

103,677

553,704

42%

39%

19%

100%

164,391

146,778

69,488

380,657

(%)

71%

68%

67%

69%

=
/

49

(1/2)
55

1004
12
38

75%
25%

52%48%

(%)

553,704 100%
102,654 19%
23,780
4%
92,518 17%

2
0%

380,657 69%

285,163

75%

95,494

25%

198,566
182,091

52%
48%

50

(2/2)

45~65
39%65-80
31%80
16%

148%
222%
310%

15
15~30
30~45
45~65
65~80
80

1
2
3
4
5

(%)

380,657 100%
20,483
8,989
26,962
146,838
118,516
58,869

5%
2%
7%
39%
31%
15%

76,141
181,806
83,352
28,145
8,261
2,952

20%
48%
22%
7%
2%
1%
51

100

(994
12)

(1004
12)

(%)

1.198

1.048

-12.46 %

4,083

3,951

-3.23 %

5.094

4.960

-2.63 %

0.040

0.035

-12.31 %

3.7
52


(
)

(
)
10.0

0.0

10

15

20

0.0

-10.0

-20.0

15

20

-20.0

-30.0

-30.0

-40.0

()

()

(
)

()
2.0

30.000

0.0
-2.0

10

-10.0

20.000
0

10

15

20

10.000

-4.0

0.000

-6.0

-10.000

-8.0

10

15

20

-20.000

-10.0

-30.000

-12.0

()
()

53

()

(
)
0.0

10.0
0

10

20

30

40

50

60

70

80

-10.0

0.0

-20.0

-10.0

-30.0

-20.0

40

60

80

-30.0

-40.0

()

()

10.00

20

(
)

(
)

30.000
20.000

5.00

10.000

0.00
0

10

20

30

40

50

60

70

80

0.000

-5.00

-10.000

-10.00

-20.000

20

40

60

80

-30.000

-15.00
()

-40.000
()

54


(
)

(
)

20.0

20.0

0.0

0.0
0

20

40

60

80

100

120

-20.0

-20.0

-40.0

-40.0

-60.0

-60.0
()

40

60

80

100

120

()

(
)

(
)

80.00

20

200.0
150.0

60.00

100.0
40.00

50.0

20.00

0.0

0.00

-50.0
0

20

40

60

80

100

20

40

60

80

100

120

-20.00

-100.0

-40.00

-150.0
()

()

55

100_(1/4)
4.00

3.50

(%)

3.36

3.00
2.50

2.47

2.00

1.94

1.50

1.46

1.00

1.00
0.89

0.50

2.81

-16.3%

2.07

-16.4%

1.62
1.24
0.90

-16.5%
-14.8%
-9.7%
-10.8%

0.80

0.00

56

100_(2/4)
8,000

(%)

7,000

6,951

6,498

6,007
5,560
4,831
4,036

6,000
5,000

4,000

5,702
5,233
4,623
3,960

-6.5%
-5.1%
-5.9%
-4.3%

-1.9%

3,000
2,512

2,000

2,433

-3.2%

1,000
0

57

100_(3/4)
12.00

10.95

(%)
10.24 -6.5%

10.00
8.69
8.00

7.30

6.00

5.93

-5.9%

6.92

-5.3%
-4.0%
-1.4%

5.69
4.55
3.87

4.61

4.00

8.18

3.90

-0.8%

2.00
0.00

58

100_(4/4)
0.120

0.112

(%)

0.100
0.080

0.084

0.087

-21.8%

0.067

0.067

-19.8%
-20.8%
-13.7%

0.060

0.053

0.048

0.041
0.033

0.040
0.037
0.020

0.030

0.028

-13.1%
-6.4%

0.000

59

1004~12

1_
2_

3_
4_

5_

()

()

()

(%)

176

94.1%
23.3

184
44.5

169

90.4%
14.7

160

()

98.4%

85.6%
18.7

178

()

95.2%
32.3

186

99.5%

1921871
10010~12186
60

100
99100Q1100Q1
47.2
100412(Q2Q4)55.5
133.6

100Q1

100(Q2-Q4)

()

()

()

15.9

20.4

53.7

90.0

6.6

7.6

17.1

31.2

10.2

12.3

24.3

46.8

4.7

8.2

16.2

29.2

8.3

5.1

18.8

32.3

1.4

1.8

3.5

6.7

47.2

55.5

133.6

236.2

100
()

61

101(1/2)

100400

()150

43
1.

()
150200

2. ()

150
3. ()

100150
62

101(2/2)
3

(994~1003)
(100
4~1013)

63

101

(C)
(D)

(A)

36

182,321

10,474

4,606

197,401

37

72,454

398

277

73,129

43

70,196

466

3,093

73,755

32

58,521

1,709

1,069

61,299

37

43,519

432

1,558

45,509

10,955

196

11,151

193

437,966

13,479

10,799

462,244

193B33,882

64

(1
1
1
)

(
)

99%
(

65

101

66

67

67

Leavell and Clarks (1)

(Primary Prevention)

68

Leavell and Clarks (2)

(Secondary Prevention)

(Tertiary Prevention)

69


100126
42

44

70

71

(1)

72

(2)
44

73

10071103630
1011103
1231

100101

3
74



-
-

(100)
(100)

75

76

()

77

(1)

78

(2)

(
)

79

-
:

80

-
:

81

-
:

:
()

()

82

83


()

(1+
+
)

84

(60%)6

=()60%
(40%)4

=()40%

85

=()(1-
) 50%1

86

(1)
10%20%
()

250%
(540%

8%)

87

(2)
()10%

80%()
10%70%-79%
5%
10%20%

65

88

89


3100331

10(
)
4-5
515100515

5-6
71

90

15,614

61,923

( 5
)

5,976

5
6
7

20,094
30,014
8,664
157,084

14,799

91

:()

92

()() -5%()

(HbA1c)
(Fasting Lipid

Profile)

65

10%
10%
8%
8%
8%
8%
8%
10%
10%
10%

.80%20%

93

100Q3~101Q1()

_A
_B
_C

_A
_B
_C

-20.7%
-11.1%
-7.0%
10.4%
-20.3%
-10.2%
-0.1%
18.3%
-26.2%
-13.1%
-4.1%
3.8%
-28.5%
-19.6%
-8.6%
5.6%
-13.8%
-3.7%
25.6%
7.6%
18.6%
29.2%
-1.0%
5.6%
-9.0%
42.9%

.100Q3-101Q1101Q1

94

100Q3~101Q1()

_A
_B
_C

_A
_B
_C

-5.5%
-1.7%
7.9%
29.8%
-0.7%
-0.8%
11.5%
31.3%
0.1%
-1.7%
17.4%
37.1%
-8.5%
8.8%
10.1%
31.8%
-9.9%
0.4%
-7.8%
-0.1%
-5.8%
1.3%
3.8%
3.3%
-4.3%
2.4%
4.1%
15.4%

.100Q3-101Q1101Q1

25%5

95

()

()()
28.80%
(HbA1c)
86.55%

(Fasting Lipid Profile)

65

10%
8%
8%

62.89%

8%

30.32%
32.50%
26.58%
31.60%

8%
8%
10%
10%

.9971006

96

1011

()()

(HbA1c)

(Fasting Lipid Profile)

65

7
7
6
85.71%
7
4
57.14%

85.71%

7
7
7
7

6
6
5
3

85.71%
85.71%
71.43%
42.86%

.1(101Q1)
3(100Q3-101Q1)

97

1011

80%

1 17.5%

3 100.0%

75

1 100.0%

75

66.7%

75

33.3%

DNR

DNR

1 100.0%

25

0.0%

50.0%

15%
2.

1.17.5%
2.115%1
2.5%

98

(
)

99


(101)163

100

101

(1/2)
1013

:
:


: 3

3
5

102

(2/2)
:
7

1
1

103

104

104

105

105


(101.9)

(102)

BC (99
)

(100

)
CKD

92%97
106

106

BC

CKD
: 1.101
2.9581

107

107

(1/2)

1.

2.

1.

2.
3.

HBA1C
LDL

(report)

108

(2/2)

BC

BC

109

40020080096
(
)

400200800(
)

14

200200500(
)

()

BC

1000150040%60%

100100100500

110

()

()

()

()

95

96

97

98

99

100

101Q1

7.25

7.86

5.04

2.87

5.87

4.87

4.998

1.88

2.02

2.04

1.94

2.89

3.89

0.634

25.9%

25.7

49.3

79.77

12.69%

3.56

4.27

4.24

2.99

3.0

3.0

2.12

2.04

1.49

1.30

1.29

1.41

1.48

0.359

57.3

35

30.8%

42.7

46.9

49.26%

16.93%

40.5 67.4

193-100101Q1P

2P
111

95

96

97

98

99

100

101Q1

7.25

7.86

5.04

2.873

5.873

4.873

4.998

1.88

2.02

2.039

1.936

2.893

3.887

0.634

1.02

1.11

1.39

1.496

1.945

2.283

0.547

0.24

0.15

0.16
0.07
0.25

0.162
0.07
0.208

0.169
0.072
0.53

0.175
0.094
0.901

0.044
0.02

0.43

0.044

BC

0.16
0.13
0.37

0.431

0.147
0.03

0.347
0.087

*3
0.023

25.7

67.4

49.3%

79.77%

12.69%

25.9%

40.5

*3

1.
2.95-100101Q11013
3.P

112

95

96

97

98

99

100

101Q1

3.56

4.27

4.236

2.99

3.00

3.00

2.12

2.04

1.49

1.303

1.290

1.406

1.478

0.359

0.45

0.48

0.60

0.684

0.768

0.832

0.203

1.21

0.60

0.51

0.473

0.471

0.438

0.118

0.29

0.39

0.18

0.133

0.137

0.138

0.024

0.019

0.018

BC

0.07

0.004
0.026

0.011
0.058

0.014

57.3

35

30.8% 42.7

46.9%

49.26%

16.93%

*3

1.
2.95-100101Q11011-3
3.P
113

114

-()

94

95

96

97

98

99

160,889

176,475

181,098

191,251

214,340

254,504

283,748

11.49%

212,137

184,269

190,671

140,464

119,645

115,788

115,423

115,600

0.15%

56,120

5,852

6,927

8,438

9,807

10,743

11,678

11,827

1.28%

10,196

98,960

123,392

76,667

54,698

54,481

65,528

20.28%

13,802

100

100/99

101Q1

36,580

43,076

17.75%

28,606

BC

44,035

91,840

108.56%

36,580

516,701

593,061

14.78%

351,010

473,033

453,392

397,370

395,569

352,429

1
295
399BC
115

-()

94

95

96

97

23.52%

23.16%

24.67%

26.34%

27.56% 29.26%2 31.16% 23.51%

32.50%

34.78%

35.17%

31.29%

31.61% 47.02% 45.45% 52.33%

12.09%

12.98%

13.60%

14.64%

14.50% 14.62% 13.67% 15.29%

9.31%

6.54%

3.93%

2.65%

98

991

2.55%

100

2.94%

101Q1

0.79%

40.65% 46.94% 30.73%

BC

9.83% 19.37% 18.70%

1 :
:()
(
BC)
2 997887(+12%)
116

-()

94

95

96

97

98

119,828

123,289

127,842

135,926

154,512

24.47%

23.77%

25.51%

27.61%

30.06%

31.30%

35.01%

16.84%

36,267

33,686

27,029

23,534

23,911

25,006

24,860

12,440

13.54%

13.93%

14.34%

14.60%

15.75%

21.73%

20.87%

23.54%

5,852

6,927

8,438

9,807

10,743

11,678

11,827

10,196

12.09%

12.98%

13.60%

14.64%

14.50%

14.62%

13.67%

15.29%

---

25,138

30,821

18,709

19,621

26,140

5,988

---

2.62%

3.16%

1.87%

1.92%

2.48%

0.77%

---

---

---

---

35,585

41,846

27,679

---

---

---

---

40.95%

54.8%

35.85%

BC

---

---

---

---

23,580

55,580

22,520

---

---

---

---

6.79%

15.11%

14.35%

99

100

101Q1

188,827 209,647 154,359

1 :
:()(
BC)
2997887(+12%)

117

-()

95

96

97

98

99

100

101Q1

43,897

54,717

54,410

56,408

61,007

66,866

74,561

57,849

14.84%

16.55%

19.67%

20.80%

20.01%

19.74%

21.79%

25.79%

150,778

159,302

114,610

97,228

92,672

91,038

91,203

43,748

44.50%

46.43%

48.12%

43.94%

40.96%

65.71%

63.03%

78.22%

98,960

98,305

45,865

36,007

34,870

39,393

7,815

9.31%

8.89%

3.98%

2.89%

2.69%

2.92%

0.77%

---

---

---

---

995

1,230

927

---

---

---

---

32.21%

17.6%

12.97%

BC

---

---

---

---

20,645

36,366

14,060

---

---

---

---

16.13%

26.36%

34.18%

94

1 :
:()
(BC)
2997887(+12%)
39999493
6099493602
118

-(1/4)

HbA1C
100.0%

99.8% 99.7% 99.6% 99.4%

97.4% 99.3% 99.7%

90.0%
80.0%

70.0%
64.7% 64.6% 63.0% 62.5%

70.0%

71.0%

68.7% 67.6%

57.7%

60.0%
50.0%

66.4% 64.3% 64.4% 66.3%

54.1%

47.1% 47.6%

44.4%

57.5%

60.8%

63.7%

47.8%

40.0%

30.0%
16.9% 16.7% 15.6%
14.3% 13.1% 14.6% 15.7%

20.0%
10.0%

6.7%

7.8%

94

95

11.7%

14.5%

21.4%
17.3% 19.2%

0.0%
94

95

96

97

98

99 100 94

95

96

97

98

99 100

96

97

98

99

119

100

-(2/4)
94-99HBA1C9.5%66%

HBA1C
9.5%

53,911

1HBA1C

7%

9,451

17.5%

7%~9.5%

26,304

48.8%

9.5%

18,156

33.7%

120

-(3/4)
9495-100
HbA1C7.0%()
34.0%

31.8%

32.2% 31.9% 32.1%

30.0%

LDL130()

HbA1C9.5%()
85.0%

32.9%

32.8%

32.0%

35.0%

83.7%
82.2%

29.8%
79.0% 79.5%

80.0%
25.0%

30.0%

76.3%

75.0%

20.0%

28.0%

71.7%

15.5%
15.0%

26.0%

14.0%

12.9% 12.2% 12.1%

11.9% 70.0%

24.5%

10.0%

24.0%

65.8%
65.0%

5.0%

22.0%

0.0%

20.0%
94 95 96 97 98 99 100

60.0%
94 95 96 97 98 99 100

94 95 96 97 98 99 100

946.8
121

121

-(4/4)

94-100

48,796

295

0.60%

402,295

17,339

4.31%

208,186

7,455

3.58%

659,277

25,089

3.81%

94100(
08902250)
94~100ID
()58540301403114039140402
4040340412404134049240493
122

-
Kaplan-MeierLife table

98.62% 9998.40%
195.64% 9994.41%
290.35% 9989.07%

373.48% 9970.75%
434.82% 9933.79%

99

123

-(1/3)

0 .15

0.118

0.12
0.112

0 .12

0.121
0.119

0 .09

()
0 .06

0.063

0.056

0.063
0.057

0.054

0 .03

()
0

96

97

98

99

100

0.06
0.05
0.041
0.04
0.03
0.035
0.034
0.02
0.01 0.019 0.017
0.015
0

96

97

98

0.037
0.018

99

()

0.028
0.013()

100

124

-(2/3)

4,000

3,502

6,000

3,627 3,589

5,929

5,900

3,551
5,800

2,500

2,721

2,841

5,642
2,936

5,664

5.00

4.70

5.07 5.11

4.82 4.90

4.00

3.00

5,200

1,500

5.67

5,578

5,400

2,000

5,783

5,600

2,823

2,552

5.70 5.70
5.70
5.65

5,722

3,000

6.00

5,897

3,297

3,500

5,123 5,335
2.00

5,000

1,000

1.00
500

4,800
0.00

96

97

98

99

100

96 97 98 99 100

4,600
96

97

98

99 100

125

45,000

40,000
35,000

40,000

33,688

48.84%

16,456
15,505

30,000
25,000

20,000
15,000

35,000
30,000
25,000

20,630

20,000
15,000
10,000

10,000

60.96%

12,578
11,791

5,000
5,000
-

SBP140mmHg

6 1
SBP<140mmHg

DBP90mmHg

6 1
DBP<90mmHg

DBP<90mmHg

SBP<140mmHg

96100

126

-(1/5)
100

11

10

27

25

41

35

11

90

79

9981
74
127

-(2/5)
100

(A)

(B)

(B/A)

55,330

32,708

59.11%

19,970

7,132

35.71%

10,440

292

2.80%

85,740

40,132

46.81%

4,052

2,325

57.38%

1,465

600

40.96%

509

19

3.73%

6,026

2,944

48.85%

91,766

43,076

46.94%

:1.

2.9989,98936,58440.65%

128

-(3/5)
100

99

100

1.3285

1.3107

1.2538

5.7%

4.1%

6.1%

4.6%

20%

19.1%

21.0%

48.3%

37.4%

20%

23.6%

24.9%

111.3%

78.9%

20%

21.7%

1.5%

22.8%

1.5%

0.7%

0.5%

1.9%

1.0%

12.8658

13.6462

28.8890

23.8899

23.8%

24.7%

67.4%

49.4%

64.4%

62.5%

64.4%

62.5%

20%

1.3950

20%

99

100

60%

100%

1.100__

__99
2.100_99

129

-(4/5)
100

99

42,603

128.0

21.7

4,145

50,917

100

42,556

129.7

23.1

4,056

54,389

-47

1.7

1.6

-89

3,472

1. 1004307699~100
2. 2&2

-(5/5)

12,975 22,693

24.5

1,590

182.5
140.6
(80/)

188,899

100 12,270 22,478

23.6

1,400

166.8
135.9
(74/)

192,724

-190

-15.7
(-6/)

99

-705

-215

-0.9

-4.7

3,825

30.1%

28.5%

-1.6%

1. 1004307699~100

2. ID
3. = / 10043,076
131

-BC(1/2)

109

80.73%

26,832

48.13%

212

193

88.08%

17,569

47.90%

18

302

85.43%

44,401

48.04%

230

1.100
2.
3.
50
20
132

-BC(2/2)
GOT
120.0%

120.0%

100.0%

GPT

97.6%

97.5%

100.0%

120.0%

98.2%

98.1%

97.4%

100.0%

97.0%

84.6%
80.2%
80.0%

80.0%

68.8%

75.2%

80.0%

72.7%

65.4%

60.0%

60.0%

60.0%

40.0%

40.0%

40.0%

20.0%

20.0%

20.0%

0.0%

0.0%

0.0%

99

100

99

100

99

100

99-100BC()
133


59.3

HBA1C99.47%
(HbA1C9.5%)
66%

2-3
48.84%()
60.96%()
11.6
0.9
BCGOTGPT

134

135

136

1. 1. 1.

2.
2.
2.
3.
3.
4.
4.DRGs 5.

6.

137


(4)

(4-6)

(7)




138

100101480

139

140

-1

141

-2

142

143




PHE

144


100-101

8(99-101)

9941101331
1001,704

145

100329
10010310116101411

146



9910010012
100996.2
17%16%

100100

10%17%


147

DA

148

96

97

98

99

100

01-12

()

()

()

637.0
718
44.8%
215.0
7,481
14.0%
852.0
930
28.8%

5.12%

2.28%

-0.68%

-1.56%

-3.48%

-4.52%

3.35%

0.58%

-1.00%

01-12

695.7

769

45.6%

225.8

7,763

14.1%

921.5

986

29.5%

9.21%

7.10%

1.69%

5.01%

3.76%

0.96%

8.15%

6.09%

2.38%

01-12

736.5

784

45.2%

230.4

7,723

14.0%

966.9

997

29.5%

5.87%

1.99%

-0.75%

2.02%

-0.51%

-0.93%

4.93%

1.12%

0.14%

01-12

755.6

786

44.4%

224.9

7,379

13.4%

980.5

988

29.0%

2.58%

0.17%

-1.77%

-2.36%

-4.45%

-4.10%

1.41%

-0.97%

-1.66%

01-12

829.6

836

45.3%

241.4

7,759

13.9%

1,071.0

1,046

30.1%

9.79%

6.37%

1.93%

7.33%

5.14%

4.08%

9.23%

5.86%

3.60%

110168
2
149

-1

CTMRI90CTMRI

ESWL

150

-2


ACT code (AIDSBC
)

Tygacil(B024443248)
18

151

10070
2915
263,051
0.01%
152

100241.2

30%1,44
3
1002

4515
1002.8

153



26

20
20

IC
DRG
ICD-10-CM/PCS

154


1.
2.

3.

155

156

157


()-1

158


()-2

25

100

Potassium-sparing diureticsAldosterone antagonist

159


()-3

160


()-4

161


()-1

162


()-2

HbA1c

HbA1c

163

()-1
25

1.

2.
3.

4.24

164

()-2
1.1 7

981

982

983

984

98

991

992

993

994

99

7
7

7
7

7
7

7
7

7
7

7
7

7
7

7
7

7
7

3,778
53,810
7.02%
3,018
45,756
6.60%
1,974
32,013
6.17%
37,166
88,353
42.07%
45,936
219,932
20.89%
9,564
52,881
18.09%
3,379
48,951
6.90%
3,103
43,150
7.19%
2,619
42,116
6.22%
18,665
187,098
9.98%

1,389
18,508
7.50%
1,092
16,206
6.74%
924
12,745
7.25%
18,341
43,740
41.93%
21,746
91,199
23.84%
4,272
22,872
18.68%
1,609
20,703
7.77%
1,290
17,010
7.58%
1,390
18,314
7.59%
8,561
78,899
10.85%

2,989
31,065
9.62%
2,282
24,226
9.42%
1,680
17,673
9.51%
25,280
60,755
41.61%
32,231
133,719
24.10%
5,322
29,644
17.95%
2,360
25,276
9.34%
2,077
23,085
9.00%
2,270
24,931
9.11%
12,029
102,936
11.69%

1,333
17,592
7.58%
915
13,154
6.96%
679
9,633
7.05%
14,785
31,595
46.80%
17,712
71,974
24.61%
3,783
17,419
21.72%
1,056
14,453
7.31%
995
13,743
7.24%
974
13,643
7.14%
6,808
59,258
11.49%

2,810
30,293
9.28%
2,078
24,063
8.64%
1,530
18,702
8.18%
15,858
46,004
34.47%
22,276
119,062
18.71%
5,871
29,631
19.81%
2,176
25,878
8.41%
2,117
24,595
8.61%
2,345
26,332
8.91%
12,509
106,436
11.75%

353
6,102
5.78%
282
5,068
5.56%
171
3,285
5.21%
3,206
8,709
36.81%
4,012
23,164
17.32%
1,010
5,354
18.86%
525
6,900
7.61%
258
4,460
5.78%
325
5,304
6.13%
2,118
22,018
9.62%

165

-1
99~100

1009281002660194

()3
x(120%)(+)

(-)

166

-2
()99100

()ATC

()6

()3
3()

167

-1

4.01%

983.27%
993.32%
1003.29%

8.59%

987.09%
997.10%
1006.99%

9821.30%
9921.99%
10022.67%

10.84%

9821.84%
9910.90%
1007.86%

1.16%

980.98%
990.89%
1000.78%

168

-2

0.91%

990.76%
1000.75%

0.47%

990.39%
1000.39%

0.59%

990.49%
1000.48%

1.01%

990.84%
1000.85%

0.82%

990.68%
1000.68%

10

1.87%

991.56%
1001.53%

1.99
2.3x(1+20%)
169

-3

11

()

991.92%
1001.86%

12

()

990.69%
1000.67%

13

(
)

991.22%
1001.14%

14

991.71%
1001.73%

15

991.95%
1001.88%

16

995.20%
1005.08%

1.99

2.1

170

-4

17

9936.18%
10039.17%

()

991.80%
1001.77%

()

999.33%
1008.10%

8.25%

997.19%
1007.14%

18

19

21

3.17%

982.61%
992.82%
1002.73%

23

3
()

9916.50%
10014.76%

24

ESWL

1.271
%

981.14%
991.14%
1001.15%

1.100
2.99

171

-5

20

22

37.22%

9834.20%
9934.99%
10034.04%

20.93%

9820.39%
9920.68%
10019.38%

172

173

174

RBRVS

175

176